FAM78B Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-49061
Key Product Details
Species Reactivity
Validated:
Human
Predicted:
Mouse (100%), Rat (100%). Backed by our 100% Guarantee.
Applications
Immunohistochemistry, Immunohistochemistry-Paraffin
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
This antibody was developed against a recombinant protein corresponding to amino acids: MNTTTKEKIILQTIKWRMRVDIEVDPLQLLGQRARLVGRTQQEQPRILSRME
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FAM78B Antibody
Immunohistochemistry: FAM78B Antibody [NBP2-49061]
Immunohistochemistry: FAM78B Antibody [NBP2-49061] - Staining of human stomach, upper shows strong cytoplasmic positivity in glandular cells.Applications for FAM78B Antibody
Application
Recommended Usage
Immunohistochemistry
1:20 - 1:50
Immunohistochemistry-Paraffin
1:20 - 1:50
Application Notes
For IHC-Paraffin, HIER pH 6 retrieval is recommended.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
PBS (pH 7.2) and 40% Glycerol
Preservative
0.02% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: FAM78B
Alternate Names
family with sequence similarity 78, member B, hypothetical protein LOC149297, MGC131653
Gene Symbol
FAM78B
Additional FAM78B Products
Product Documents for FAM78B Antibody
Product Specific Notices for FAM78B Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...